addarrow-downarrow-leftarrow-rightarrow-up82CF3E98-D323-4B3E-9EDD-EF2E73FB5C9E@1xcancelclosedowndownloademailIcons / Social / FacebookfilterhomeIcons / Social / InstagramleftIcons / Social / LinkedIn895A4639-EEE0-4BEB-B7D1-CAB21217861B@1xMenu IconremoverightSearchtagtik-toktimeline-arrow-lefttranslateIcons / Social / TwitterupIcons / Social / YouTube

Dr Mahesh Shah

Dr Mahesh

Dr. Mahesh Shah (MBBS, DD, MD-Dermatology) is the Medical Director at Anandaban Hospital, The Leprosy Mission Nepal. He has got 30 years of experience in diagnosing and treating leprosy patients and managing leprosy complications. He has been actively involved in research activities and is the principal investigator for different clinical studies being carried out at Anandaban Hospital. In addition, he is the chief resource person for Leprosy Trainings being organized at Institutional Level and National Level.

Contact

Email: maheshs@tlmnepal.org
Phone: +9779841203417

Publications

  1. Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial. Barbara de Barros, Saba M Lambert, Mahesh Shah, Vivek V Pai, Joydeepa Darlong, Benjamin Jewel Rozario, Medhi Denisa Alinda, Anna M Sales, Shimelis Doni, Deanna A Hagge, Dilip Shrestha, M Yulianto Listiawan, Abeba M Yitaye, Jose A C Nery, Kapil D Neupane, Vivianne L A Dias, C Ruth Butlin, Peter G Nicholls, Diana Lockwood, Stephen L Walker. BMJ Open. 2020 Nov 17;10(11):e037700.
  2. Histopathological pattern of skin cancer at tertiary referral skin health centre R. C.Adhikari, M.Shah, A. K. Jha Journal of Pathology of Nepal (2019) Vol. 9, 1555-1559
  3. Histopathological spectrum of skin diseases in a tertiary skin health and referral centre R. C.Adhikari, M.Shah, A. K. Jha Journal of Pathology of Nepal (2019) Vol. 9, 1434-1440
  4. Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy. Toh HS, Maharjan J, Thapa R, Neupane KD, Shah M, Baral S, Hagge DA, Napit IB, Lockwood DNJ.PLoS Negl Trop Dis. 2018 Jul 2;12(7):e0006610. doi: 10.1371/journal.pntd.0006610. eCollection 2018 Jul. PMID: 29965957
  5. Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial. Wagenaar I, Post E, Brandsma W, Bowers B, Alam K, Shetty V, Pai V, Husain S, Sigit Prakoeswa CR, Astari L, Hagge D, Shah M, Neupane K, Tamang KB; TENLEP study group, Nicholls P, Richardus JH.PLoS Negl Trop Dis. 2017 Oct 4;11(10):e0005952. doi: 10.1371/journal.pntd.0005952. eCollection 2017 Oct.
  6. Opening a Can of Worms: Leprosy Reactions and Complicit Soil-Transmitted Helminths. Hagge DA, Parajuli P, Kunwar CB, Rana DRSJB, Thapa R, Neupane KD, Nicholls P, Adams LB, Geluk A, Shah M, Napit IB. EBioMedicine. 2017 Sep;23:119-124. doi: 10.1016/j.ebiom.2017.08.026. Epub 2017 Sep 1.
  7. A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale. Walker SL, Sales AM, Butlin CR, Shah M, Maghanoy A, Lambert SM, Darlong J, Rozario BJ, Pai VV, Balagon M, Doni SN, Hagge DA, Nery JAC, Neupane KD, Baral S, Sangma BA, Alembo DT, Yetaye AM, Hassan BA, Shelemo MB, Nicholls PG, Lockwood DNJ; Erythema Nodosum Leprosum International STudy Group. PLoS Negl Trop Dis. 2017 Jul 3;11(7):e0005716. doi: 10.1371/journal.pntd.0005716. eCollection 2017 Jul.PMID: 28671966
  8. Cutaneous leishmaniasis. R.C.Adhikari, M. Shah. Journal of Pathology of Nepal(2017) Vol.7,1212-1217.
  9. ENLIST 1: an international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum. Walker SL, Balagon M, Darlong J, Doni SN, Hagge DA, Halwai V, John A, Lambert SM, Maghanoy A, Nery JA, Neupane KD, Nicholls PG, Pai VV, Parajuli P, Sales AM, Sarno E, Shah M, Tsegaye D, Lockwood DN; Erythema Nodosum Leprosum International STudy Group. PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0004065. doi: 10.1371/journal.pntd.0004065. eCollection 2015. PMID: 26351858
  10. Skin disease is common in rural Nepal: results of a point prevalence study. Walker SL, Shah M, Hubbard VG, Pradhan HM, Ghimire M. Br J Dermatol. 2008;158(2):334-8. doi: 10.1111/j.13652133.2007.08107.x. PubMed PMID: 17711533.
  11. Leprosy blindness in Nepal. Gupta HR, Shakya S, Shah M, Pradhan HM. Nepal Medical College journal : NMCJ. 2006;8(2):140-2. PubMed PMID: 17017408.
  12. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. The Journal of infectious diseases. Haslett PA, Roche P, Butlin CR, Macdonald M, Shrestha N, Manandhar R, Lemaster J, Hawksworth R, Shah M, Lubinsky AS, Albert M, Worley J, Kaplan G. 2005;192(12):2045-53. doi: 10.1086/498216. PubMed PMID: 16288366.